THE POLICY EDGE

Department of Pharmaceuticals DoPs

Search
Showing 1-12 of 19 articles
Policy Bites

Health Ministry Proposes Import Reforms to Support Pharmaceutical R&D and Medicine Availability

26 Jun 2026
Policy Bites

NPPA Integrates Medicine Price Check and Complaint Portals into a Single Platform

25 Jun 2026
Reports/Data Releases

India’s Trade Growth Holds Firm as Services Exports Rise and API Dependence Persists

23 Jun 2026
Policy Bites

India’s Pharmaceutical Sector Expands from Affordable Access to Biopharma Innovation

18 Jun 2026
Reports/Data Releases

OECD Report Warns Pharmaceutical Supply Chains Face Rising Environmental and Governance Risks

11 May 2026
Policy Bites

Shift from Patents to Products Drives Biopharma Push at NIPER

02 May 2026
Policy Bites

India Pharma 2026: Government Pushes Shift from Generics to Biopharma Innovation

13 Apr 2026
Opinion

India’s Hypertension Treatment Needs Simpler Pathways

Prabhakaran Dorairaj, Centre for Chronic Disease Control; Ambuj Roy, AIIMS, New Delhi.

07 Apr 2026
Policy Bites

The Indo-Australian Biotech Bridge: Strategic Synergies in Clinical Trials

01 Apr 2026
Policy Bites

The Pharmacy of the World: A 2026 Overview of India’s Pharmaceutical Sector

22 Mar 2026
Opinion

The Next Frontier for India’s Defence Against Antimicrobial Resistance Is Governance, Not Just New Drugs

Sudha Chandrashekar, Health Systems Transformation Platform (HSTP); Shambhavi Nimisha Prasad, Kempegowda Institute of Medical Sciences (KIMS); Ramesh Masthi N R, Kempegowda Institute of Medical Sciences (KIMS) ...

13 Mar 2026
Policy Bites

Strengthening Self-Reliance in Active Pharmaceutical Ingredients

10 Mar 2026

Rethinking Public Policy Through Insight | Inquiry | Impact

Opinion • Grassroots Voices • Policymakers Perspectives • Expert Analysis • Policy Briefs